???While data supporting EM as a management option for men with low-risk prostate cancer has matured, rates of EM have not correspondingly increased,??? said Scott Eggener, MD, Associate Professor, Urologic Oncology, University of Chicago. ???The VA system appears to have led the way in adoption of EM, suggesting factors such as patient population, practice setting or even reimbursement models may